Figure 1
Figure 1. BeigeJ and souris mice reproduce the clinical and immunologic phenotype of CHS. (A) Top panel: Diluted coat color of beigeJ and souris mice. Middle panel: Uneven distribution of pigment in the hair shafts. Bottom panel: Typical inclusion bodies in granulocytes (white arrows). (B) Scheme of the LYST protein with indicated mutation sites in souris and beigeJ mice. The mutation of souris mice is shown on genomic DNA level (position 92815; NCBI Reference Sequence NC_000079), whereas the beigeJ mutation is shown on cDNA level (NCBI Reference Sequence NM_010748.2). (C-E) NK-cell degranulation and cytotoxicity. Mice were injected intraperitoneally with polyinosinic acid/polycytidylic acid, and spleen cells were analyzed 24 hours later. (C) Representative FACS plots of NK-cell degranulation showing CD107a surface expression on NK1.1+CD3− cells after restimulation with YAC-1 cells or medium control. (D) Degranulation is shown as percentage increase of CD107a expression on NK1.1+CD3− cells (ΔCD107a) after restimulation with YAC-1 cells compared with medium control. (E) Lytic activity of NK cells on YAC-1 target cells as determined in a 51Cr-release assay. (D-E) Data show results from one of 2 independent experiments with 3 mice per group. ***P < .001.

BeigeJ and souris mice reproduce the clinical and immunologic phenotype of CHS. (A) Top panel: Diluted coat color of beigeJ and souris mice. Middle panel: Uneven distribution of pigment in the hair shafts. Bottom panel: Typical inclusion bodies in granulocytes (white arrows). (B) Scheme of the LYST protein with indicated mutation sites in souris and beigeJ mice. The mutation of souris mice is shown on genomic DNA level (position 92815; NCBI Reference Sequence NC_000079), whereas the beigeJ mutation is shown on cDNA level (NCBI Reference Sequence NM_010748.2). (C-E) NK-cell degranulation and cytotoxicity. Mice were injected intraperitoneally with polyinosinic acid/polycytidylic acid, and spleen cells were analyzed 24 hours later. (C) Representative FACS plots of NK-cell degranulation showing CD107a surface expression on NK1.1+CD3 cells after restimulation with YAC-1 cells or medium control. (D) Degranulation is shown as percentage increase of CD107a expression on NK1.1+CD3 cells (ΔCD107a) after restimulation with YAC-1 cells compared with medium control. (E) Lytic activity of NK cells on YAC-1 target cells as determined in a 51Cr-release assay. (D-E) Data show results from one of 2 independent experiments with 3 mice per group. ***P < .001.

Close Modal

or Create an Account

Close Modal
Close Modal